Cargando…
Optimizing individualized treatment strategy based on breast cancer organoid model
Autores principales: | Pan, Bo, Li, Xuelu, Zhao, Dongyi, Li, Ning, Wang, Kainan, Li, Man, Zhao, Zuowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012563/ https://www.ncbi.nlm.nih.gov/pubmed/33931968 http://dx.doi.org/10.1002/ctm2.380 |
Ejemplares similares
-
Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model
por: Li, Xuelu, et al.
Publicado: (2020) -
Establishment and characterization of breast cancer organoids from a patient with mammary Paget’s disease
por: Pan, Bo, et al.
Publicado: (2020) -
A novel treatment strategy of HER2-targeted therapy in combination with Everolimus for HR+/HER2- advanced breast cancer patients with HER2 mutations
por: Ma, Jing, et al.
Publicado: (2022) -
A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancer
por: Jia, Xiaomeng, et al.
Publicado: (2022) -
Clinical characteristics and clinicopathological correlations of bilateral breast cancer in China: A multicenter study from Chinese Society of Breast Surgery (CSBrS-006)
por: Li, Xuelu, et al.
Publicado: (2021)